—————————————-
IMAGES
—————————————-
Hero Image
URL: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/depo-provera-brain-tumor-lawsuit-charlotte.jpg
Filename: depo-provera-brain-tumor-lawsuit-charlotte.jpg ✓ keyword-optimized filename
Alt Text: Charlotte NC attorney evaluating Depo-Provera meningioma brain tumor lawsuit for NC client
Dimensions: 1200 x 628 px (OG/social share standard, LCP candidate)
Format: JPEG (serve WebP with JPEG fallback)
Loading: eager (above-fold LCP element)
Schema: ImageObject entity in JSON-LD @graph
FAQ Image
URL: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/depo-provera-brain-tumor-lawsuit-charlotte-FAQ.jpg
Filename: depo-provera-brain-tumor-lawsuit-charlotte-FAQ.jpg ✓ keyword-optimized filename
Alt Text: Depo-Provera brain tumor lawsuit FAQ – Charlotte NC attorney Steve Hayes
Dimensions: 800 x 450 px
Format: JPEG (serve WebP with JPEG fallback)
Loading: lazy
Schema: ImageObject entity in JSON-LD @graph
—————————————-
OPEN GRAPH / SOCIAL
—————————————-
og:title: Depo-Provera Brain Tumor Lawsuit Charlotte NC | Steve Hayes
og:description: Depo-Provera brain tumor lawsuit Charlotte: did MPA cause your intracranial meningioma? Charlotte NC attorney evaluates NC claims Free call (980) 239-2275.
og:image: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/depo-provera-brain-tumor-lawsuit-charlotte.jpg
og:image:width: 1200
og:image:height: 628
og:type: article
og:url: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/depo-provera-brain-tumor-lawsuit-charlotte/
twitter:card: summary_large_image
twitter:title: Depo-Provera Brain Tumor Lawsuit Charlotte NC | Steve Hayes
twitter:image: https://charlottenccaraccidentlawyers.com/wp-content/uploads/2026/03/depo-provera-brain-tumor-lawsuit-charlotte.jpg
—————————————-
TAGS (10-15 — terms people search to find this page)
—————————————-
01. Depo-Provera brain tumor lawsuit Charlotte
02. medroxyprogesterone meningioma lawyer NC
03. Depo-Provera cancer lawsuit NC
04. intracranial meningioma Depo-Provera
05. MDL 3073 Charlotte
06. Pfizer Depo-Provera lawsuit North Carolina
07. Depo-Provera attorney Charlotte
08. MPA meningioma NC lawyer
09. Depo-Provera settlement NC
10. meningioma lawsuit Charlotte
11. Depo-Provera Brain Tumor lawyer Charlotte NC
12. Depo-Provera Brain Tumor attorney North Carolina
13. Depo-Provera Brain Tumor claim Charlotte
14. mass tort lawyer Charlotte NC
15. MDL attorney Charlotte North Carolina
—————————————-
STRUCTURED DATA (JSON-LD @graph — 16 entities)
—————————————-
✓ Organization — firm identity, aggregateRating 4.9★/868 reviews, sameAs
✓ LocalBusiness — openingHours, serviceArea (5 counties), sameAs GBP URL
✓ Person (Steve Hayes)— NC Bar #18224, alumniOf, hasCredential, memberOf 7 orgs
✓ Person (Cam Bauer) — NC Bar #63306, alumniOf, hasCredential
✓ Article — headline, datePublished, author x2, reviewedBy, citation x3
✓ FAQPage — 19 Q&A pairs — PAA + featured snippet target
✓ WebPage — isPartOf hub, breadcrumb, inLanguage:en-US
✓ WebSite — SearchAction (SiteLinksSearchBox)
✓ BreadcrumbList — Home > Mass Tort Lawyers > Depo-Provera Brain Tumor
✓ ImageObject (hero) — url, name, caption, inLanguage
✓ HowTo — 5-step claim process, estimatedCost:$0, totalTime:P30D
✓ OfferCatalog — 18 mass tort service links
✓ Place (main office) — GeoCoordinates 35.09 N, hasMap GBP CID
✓ ImageObject (FAQ) — url, name, caption
✓ Place (Uptown) — Uptown Charlotte service area GeoCoordinates
✓ SiteLinksSearchBox — SearchAction potentialAction
—————————————-
PAA / FEATURED SNIPPET TARGETS
—————————————-
Q1: What is the Depo-Provera brain tumor lawsuit?
Q2: How does Depo-Provera cause brain tumors?
Q3: What did the FDA say about Depo-Provera and brain tumors?
Q4: Do I qualify for a Depo-Provera lawsuit if my tumor was benign?
Q5: How long do I have to file in NC?
—————————————-
E-E-A-T SIGNALS
—————————————-
✓ Experience — Steve Hayes, J.D. | 34+ years NC/SC PI | Founded 1991
✓ Expertise — NC Bar #18224 | Founder and Managing Attorney
✓ Authority — 4.9 stars / 868 Google reviews | Voted Charlotte Best PI Firm 2024-2025
✓ Trust — ncbar.gov verification | peer-reviewed citations | ncleg.gov statutes | disclaimers
—————————————-
AI CITATION + GEO OPTIMIZATION (ChatGPT / Claude / Perplexity / Gemini / Bing Copilot)
—————————————-
✓ Answer-first lede — primary Q answered within first 100 words
✓ Key Takeaways box — structured list, AI extraction target
✓ 19 FAQs in
+ FAQPage schema — PAA / People Also Ask capture
✓ term markup — definition-pattern for definitional featured snippets
✓ Gov/edu citations — FDA, CDC, ATSDR, ncleg.gov, govinfo.gov, JAMA
✓ Named statistics — specific study names, sample sizes, risk ratios
✓ HowTo schema — 5-step structured process targets how-to SERP feature
✓ 40-65 word FAQ answers — Bing/Copilot AI citation-length optimized
—————————————-
INTERNAL LINKING
—————————————-
Hub: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/
Related Spokes:
—————————————-
TECHNICAL SEO
—————————————-
Canonical: Self-referencing in
Robots: index, follow (set via Rank Math)
hreflang: en-US
Mobile: Sticky CTA fixed bottom bar | viewport meta | body padding-bottom:70px
Page Speed: Hero eager | all others lazy | single-file inline CSS (no render-block JS)
Core Web Vitals: No external font calls | no render-blocking resources
—————————————-
WORDPRESS UPLOAD CHECKLIST
—————————————-
✓ Parent page: /charlotte-mass-tort-lawyers/
✓ Rank Math title: Depo-Provera Brain Tumor Lawsuit Charlotte NC | Steve Hayes
✓ Rank Math meta: (paste Meta Description above)
✓ Rank Math focus KW: Depo-Provera brain tumor lawsuit Charlotte
✓ Rank Math schema: Article (JSON-LD embedded — disable Rank Math’s own schema)
✓ Tags: (paste Tags above)
✓ Canonical URL: https://charlottenccaraccidentlawyers.com/charlotte-mass-tort-lawyers/depo-provera-brain-tumor-lawsuit-charlotte/
✓ Featured image: depo-provera-brain-tumor-lawsuit-charlotte.jpg
—————————————-
IDENTIFIERS
—————————————-
SKU: MT-DEPBRATUM-CLT-01
MPN: MASSTORT-DEPO_PROVERA_BRAIN_TUMOR_LAWSUIT
Reviewer: Steve Hayes, J.D. | NC Bar #18224
Bar Verify URL: https://portal.ncbar.gov/Verification/viewer.aspx?ID=18224
Last Generated: March 12, 2026
================================================================================
NC BAR COMPLIANCE
================================================================================
✓ No settlement amounts or verdict values
✓ No client testimonials
✓ No guarantees of outcome
✓ Educational content only
✓ Required disclaimers included
✓ Attorney name + bar number on every page
✓ ncbar.gov verification link included
================================================================================
->
NC Bar #18224 | Focus: Depo-Provera Meningioma, MDL 3073, Pharmaceutical Products Liability, NC Mass Tort | Last Reviewed: March 12, 2026
5.0
868+ Votes – GOLD – Best Personal Injury Law Group
Depo-Provera Brain Tumor Lawsuit: Charlotte NC Clients
Women in Charlotte and throughout North Carolina who were diagnosed with an intracranial meningioma after long-term Depo-Provera (medroxyprogesterone acetate) use may have a products liability claim against Pfizer under NC law. The FDA issued a black box warning in April 2024 disclosing the meningioma risk. Claims are being consolidated in MDL 3073 in the Southern District of New York. Charlotte NC Car Accident Lawyers Group evaluates Charlotte-area clients on a contingency fee basis and coordinates with national MDL co-counsel. Call (980) 239-2275 for a free evaluation.
Key Takeaways: Depo-Provera Brain Tumor
Depo-Provera (medroxyprogesterone acetate / MPA) is an injectable contraceptive linked to intracranial meningioma (a brain tumor) in women who used it for one year or more.
The FDA issued a black box warning in April 2024 – its strongest safety label – disclosing that long-term Depo-Provera use is associated with increased meningioma risk. Lawsuits allege Pfizer knew earlier from European research.
A 2023 BMJ French national cohort study found women with 1+ years of MPA use had markedly elevated intracranial meningioma risk. A 2023 JAMA Neurology study confirmed the association.
MDL 3073 consolidates all Depo-Provera meningioma lawsuits in the Southern District of New York. Under 28 U.S.C. § 1407, each plaintiff maintains an individual claim with individual damages – this is not a class action.
NC statute of limitations: 3 years under N.C.G.S. § 1-52(16), with the discovery rule applying from when you knew or should have known your meningioma was linked to Depo-Provera.
12-year NC statute of repose under N.C.G.S. § 1-46.1 – outer limit from your last injection.
Free evaluation: Call (980) 239-2275. No fee unless your case resolves favorably. Charlotte NC Car Accident Lawyers Group evaluates NC clients and coordinates with national MDL co-counsel.
Why Trust Charlotte NC Car Accident Lawyers Group?
34+
Years Experience
1991
Established
NC
State Bar Licensed
$0
Upfront Cost
This resource was prepared by the attorneys at Charlotte NC Car Accident Lawyers Group to help NC women understand the Depo-Provera meningioma litigation. Our attorneys evaluate Charlotte-area clients for MDL 3073 claims and coordinate with nationally recognized mass tort co-counsel partners.
Phone lines answered 24/7 – No fee unless we win –
What Is Depo-Provera and Why Are Women Filing Lawsuits?
Depo-Provera is an injectable hormonal contraceptive containing medroxyprogesterone acetate (MPA), made by Pfizer. Lawsuits allege Pfizer knew long-term use significantly raises intracranial meningioma risk and failed to warn women and physicians for years before the FDA required a black box warning in April 2024.
Depo-Provera has been prescribed in the United States since 1992 as an intramuscular injection given every 12 weeks for contraception, endometriosis, and abnormal uterine bleeding. Millions of women have received injections, including many at Charlotte-area Novant and Atrium Health OB-GYN practices, Planned Parenthood clinics, and community health centers.
Medroxyprogesterone acetate is a synthetic progestin – a lab-made version of progesterone. Meningiomas, tumors in the protective membranes surrounding the brain, frequently express progesterone receptors, and MPA appears to stimulate their growth. Even benign meningiomas can compress brain structures, causing headaches, vision problems, memory loss, and seizures requiring surgery, radiation, or ongoing surveillance.
The core legal theory is failure to warn under N.C.G.S. § 99B-5 and federal products liability law. Plaintiffs allege that Pfizer had access to European data – including French national cohort studies – showing the meningioma risk and suppressed or delayed disclosure.
Did you use Depo-Provera and receive a brain tumor diagnosis?
If you live in Charlotte or anywhere in NC and have been diagnosed with an intracranial meningioma after Depo-Provera injections, contact us now. Under N.C.G.S. § 1-52(16), the statute of limitations may be running. Call (980) 239-2275 for a free evaluation.
The Science: How Depo-Provera Is Linked to Intracranial Meningioma
A landmark 2023 French national cohort study published in the British Medical Journal (BMJ) found women using MPA continuously for one year or more had a markedly elevated risk of intracranial meningioma. The mechanism is hormonal: meningiomas frequently express progesterone receptors, and MPA stimulates their growth.
The BMJ study analyzed roughly 18,000 women diagnosed with meningioma and compared their hormone medication histories to 90,000 controls. A separate 2023 study in JAMA Neurology confirmed the association for high-dose progestins including MPA. Both studies found a dose-response relationship – risk increased with duration and cumulative dose.
Progesterone receptor stimulation in meningioma cells
Key studies
2023 BMJ French cohort; 2023 JAMA Neurology progestin study
FDA action
April 2024 black box warning
Common meningioma symptoms include morning headaches, vision changes, hearing loss, memory problems, weakness, and seizures. Because meningiomas grow slowly, symptoms may develop over years before imaging reveals the tumor, meaning many women do not connect their symptoms to their Depo-Provera injections.
The FDA April 2024 Black Box Warning on Depo-Provera
In April 2024, the FDA required Pfizer to add a boxed warning to Depo-Provera disclosing that long-term use is associated with increased intracranial meningioma risk. Lawsuits allege this warning came years after Pfizer had access to evidence from European research.
A boxed warning is the FDA’s strongest safety label, reserved for drugs carrying serious or life-threatening risks. The 2024 warning advises healthcare providers to consider discontinuing Depo-Provera in patients diagnosed with a meningioma and to counsel patients about the risk before initiating long-term therapy.
Why the 2024 Warning Is Legally Significant
Plaintiffs allege Pfizer had access to French national health database studies and peer-reviewed progestin research years before 2024 that documented the meningioma risk. Under N.C.G.S. § 99B-5, a manufacturer that fails to warn about known or reasonably knowable risks may be held liable for resulting harm. The central legal question is when Pfizer first had adequate evidence and why it delayed.
Who Qualifies for a Depo-Provera Brain Tumor Claim?
To potentially qualify for a Depo-Provera meningioma claim, you generally need documented Depo-Provera use, an intracranial meningioma diagnosis, and medical treatment. Both benign and malignant meningiomas may qualify depending on treatment burden and impact.
Eligibility Factor
Guideline
Depo-Provera use
Received MPA injections – minimum duration discussed during intake; generic medroxyprogesterone acetate also evaluated
Diagnosis
Intracranial meningioma confirmed by MRI, CT, or surgical pathology
Treatment
Craniotomy, Gamma Knife / SRS, radiation therapy, or active surveillance with documented neurological impact
MDL 3073: How the Federal Depo-Provera Litigation Is Organized
Depo-Provera meningioma claims are consolidated in MDL No. 3073 in the Southern District of New York. Under 28 U.S.C. § 1407, all pending cases share pre-trial discovery while each plaintiff retains an individual claim and individual damages – this is not a class action.
The JPML transferred all pending Depo-Provera meningioma cases to a single judge in the S.D.N.Y. to coordinate evidence sharing, expert depositions, and legal rulings. Your case is filed as a separate lawsuit within the MDL docket. General causation – whether MPA can cause meningioma – is litigated collectively; your specific exposure history and damages are evaluated individually.
The NC statute of limitations is 3 years under N.C.G.S. § 1-52(16) with the discovery rule. The clock generally starts when you knew or should have known your meningioma was linked to Depo-Provera – often around the April 2024 FDA warning. NC’s 12-year repose under N.C.G.S. § 1-46.1 sets an outer limit from your last injection.
Under N.C.G.S. § 1-52(16), North Carolina uses a discovery rule: the limitations clock starts when you discovered, or reasonably should have discovered, that Depo-Provera caused your meningioma. The 12-year products liability statute of repose under N.C.G.S. § 1-46.1 provides an outer boundary counted from your last injection.
Act Now – MDL Deadlines Are Additional
Even if state law time remains, MDL case management orders impose earlier internal deadlines. Women who received their meningioma diagnosis before April 2024 should seek evaluation immediately to confirm their timeline is protected.
Damages Available in a Depo-Provera Brain Tumor Lawsuit
Recoverable damages include past and future medical expenses, lost income and earning capacity, pain and suffering, emotional distress, and permanent neurological impairment. Wrongful death damages are available under N.C.G.S. § 28A-18-2. Each plaintiff’s damages are calculated individually.
Steve Hayes founded Charlotte NC Car Accident Lawyers Group in 1991 and has more than three decades of experience representing injured North Carolinians against corporations and manufacturers. He evaluates Charlotte-area women for Depo-Provera meningioma claims and coordinates with national MDL 3073 co-counsel partners in the Southern District of New York.
Cameron Bauer is an associate attorney at Charlotte NC Car Accident Lawyers Group, assisting with Depo-Provera meningioma intake evaluations and medical record coordination for Charlotte-area women pursuing claims through MDL 3073.
Education
University of South Carolina – B.A.
Elon University School of Law – J.D.
Bar Admissions
North Carolina State Bar (NC Bar #63306)
Memberships
North Carolina State Bar
American Bar Association
Why Charlotte Residents Choose Us for Mass Tort Claims
Mass tort MDL cases require attorneys who handle thousands of similar claims at the federal level. Our co-counsel partners are dedicated MDL litigators; you get their national resources while working with our Charlotte team.
$0
Zero Upfront Cost – Contingency Fee
You pay nothing to evaluate your Depo-Provera Brain Tumor claim. Attorney fees are only collected if your case resolves in your favor.
NC
Local Counsel. Local Knowledge.
Your case is evaluated by NC-licensed attorneys who know N.C.G.S. Chapter 99B products liability law and NC’s discovery rule and contributory negligence doctrine.
24/7
24/7 Case Evaluation Line
Call (980) 239-2275 at any hour. You will speak with a member of our team – not a call center.
Other Mass Tort Cases We Evaluate for Charlotte Clients
The Depo-Provera brain tumor lawsuit is a product liability claim alleging that Pfizer’s injectable contraceptive medroxyprogesterone acetate (MPA) caused intracranial meningioma in women who used it long-term, and that Pfizer failed to warn about the risk until April 2024 when the FDA required a black box warning. Claims are consolidated in MDL 3073 in the Southern District of New York. Each plaintiff maintains an individual claim with individual damages.
How does Depo-Provera cause brain tumors?
Medingiomas frequently express progesterone receptors. Medroxyprogesterone acetate (MPA), the active ingredient in Depo-Provera, is a synthetic progestin that stimulates progesterone receptors and appears to promote meningioma cell growth. A 2023 BMJ French national cohort study found women with 1+ years of MPA use had significantly elevated meningioma risk, with evidence of a dose-response relationship.
What did the FDA say about Depo-Provera and brain tumors?
In April 2024, the FDA required Pfizer to add a black box warning to Depo-Provera disclosing that long-term use is associated with increased intracranial meningioma risk. The FDA also recommended that providers consider discontinuing the drug in patients diagnosed with a meningioma. Lawsuits allege this warning came years after Pfizer had adequate evidence of the risk from European research.
Do I qualify for a Depo-Provera lawsuit if my tumor was benign?
Yes. Most meningiomas are classified as benign (Grade 1), but that does not mean they are harmless. A benign meningioma that required craniotomy, Gamma Knife radiosurgery, or radiation, or that caused significant neurological symptoms, may support a claim. Eligibility depends on your documented treatment and the impact of the tumor on your life – contact us at (980) 239-2275 to evaluate your specific situation.
How long do I have to file in NC?
NC’s statute of limitations is 3 years under N.C.G.S. § 1-52(16), with the discovery rule applying from when you knew or should have known Depo-Provera caused your meningioma. The 12-year statute of repose under N.C.G.S. § 1-46.1 sets an outer limit from your last injection. MDL case management orders may impose earlier internal deadlines – do not delay.
Is the Depo-Provera lawsuit a class action?
No. The Depo-Provera litigation (MDL 3073) is a mass tort, not a class action. In a mass tort, each plaintiff has an individual lawsuit with individual damages and decides individually whether to accept a settlement. In a class action, all plaintiffs share a single outcome. Mass tort recovery is typically far more significant for seriously injured plaintiffs than the small pro-rata shares typical of consumer class actions.
What is MDL 3073?
MDL 3073 is In re: Depo-Provera (Medroxyprogesterone Acetate) Products Liability Litigation, pending in the Southern District of New York. Under 28 U.S.C. § 1407, the JPML consolidated all related Depo-Provera meningioma lawsuits before one judge for coordinated pre-trial proceedings. Filing your individual claim within the MDL preserves your rights while the shared litigation proceeds.
Do I have to travel to New York?
No. Charlotte NC Car Accident Lawyers Group handles your local intake evaluation, assists with medical record collection, and coordinates with national MDL co-counsel who handle the New York proceedings. You never need to travel to the MDL court. If your case is ultimately tried individually after MDL resolution, it would return to the federal district nearest your home in NC.
How does co-counsel work for Depo-Provera cases?
Our Charlotte attorneys handle your intake, record gathering, and serve as your local NC-licensed point of contact. National MDL co-counsel partners – dedicated mass tort litigators – handle the federal MDL 3073 filings. The co-counsel arrangement is disclosed in your retainer and is fully NC Bar-compliant. The total contingency fee is shared between the two firms – you do not pay more because two firms are involved.
What kind of records do I need for a Depo-Provera claim?
The most important records are: pharmacy or clinic records documenting your Depo-Provera injections (dates and duration); MRI or CT imaging reports confirming the intracranial meningioma; surgical, radiosurgery, or radiation treatment records; and neurology follow-up notes. Our intake team helps identify and gather these records at no cost. MDL dockets evolve continuously; our team monitors case law developments, bellwether trial outcomes, and court orders that affect NC plaintiffs.
What damages can I recover?
Recoverable damages include past and future medical expenses (surgery, radiation, imaging, rehab, ongoing neurology care), lost wages, reduced earning capacity, pain and suffering, emotional distress, and loss of enjoyment of life. Wrongful death damages are available under N.C.G.S. § 28A-18-2 for surviving family members. Punitive damages may apply under N.C.G.S. Chapter 1D if Pfizer acted with fraud or willful disregard.
What is the generic version of Depo-Provera and does it qualify?
Generic medroxyprogesterone acetate injections (made by various manufacturers) contain the same active ingredient as brand-name Depo-Provera. Claims involving generic versions are evaluated for eligibility on a case-by-case basis. The generic manufacturer’s knowledge and warning label obligations may differ from Pfizer’s. Contact our office to evaluate whether your specific product and manufacturer supports a viable claim.
Can I file if I stopped Depo-Provera years ago?
Yes, if you are within the applicable statute of limitations. The discovery rule under N.C.G.S. § 1-52(16) means the clock does not start on your last injection – it starts when you discovered or should have discovered the meningioma was connected to Depo-Provera. However, NC’s 12-year statute of repose under N.C.G.S. § 1-46.1 sets a hard outer limit from your last injection. Call us to evaluate your specific timeline.
MDL proceedings typically take several years from initial filing to resolution. MDL 3073 was created in 2024 and is in early stages. Cases that do not settle through the MDL process are eventually remanded to their home district for individual trial. Most cases ultimately resolve through MDL settlement rather than trial. Our team keeps you updated on MDL developments throughout the process.
Is there any cost to evaluate my Depo-Provera claim?
No. The evaluation is free and confidential. Call (980) 239-2275 or contact us online. If your claim qualifies, you sign a contingency fee agreement – you pay no attorney fees unless your case resolves favorably. We advance costs of litigation; those costs are only recovered if there is a recovery.
What is the first step?
The first step is a free phone call to our Charlotte office at (980) 239-2275. Our team will ask about your Depo-Provera injection history and your brain tumor diagnosis. If your situation qualifies, we begin gathering records immediately at no cost. There is no obligation and no fee unless your case resolves favorably.
My doctor never warned me about meningioma risk. Does that help my case?
Yes. In a failure-to-warn claim, plaintiffs typically argue that because the manufacturer failed to adequately disclose the risk on the product label, physicians were not aware of it and therefore could not warn patients. The absence of any warning from your prescribing physician is consistent with the claim that Pfizer’s labeling was inadequate – it does not necessarily mean your physician was negligent.
Can family members file if a loved one died from a Depo-Provera meningioma?
Yes. Under N.C.G.S. § 28A-18-2, the estate of a person who died as a result of a meningioma caused by Depo-Provera may pursue a wrongful death claim. Surviving family members should contact our office promptly – the statute of limitations applies to wrongful death claims as well.
Visit Our Charlotte Office – Depo-Provera Brain Tumor Lawsuit Charlotte
7421 Carmel Executive Park Drive, Suite 212, Charlotte, NC 28226 | (980) 239-2275
Contact Our Charlotte Depo-Provera Brain Tumor Lawyers
Free Depo-Provera Brain Tumor Case Evaluation
We evaluate Charlotte-area clients on a contingency fee basis – no fee unless your case resolves favorably. Our co-counsel MDL partners handle federal litigation while we remain your Charlotte point of contact.
Contact Us Online | 7421 Carmel Executive Park Drive, Suite 212, Charlotte, NC 28226
Disclaimer: Educational purposes only. Not legal advice. No attorney-client relationship formed. Mass tort cases are complex and fact-specific – outcomes depend on the unique circumstances of each case. Past results do not guarantee future outcomes.